HAE

HAEMONETICS CORP

Healthcare | Mid Cap

$1.22

EPS Forecast

$355.2

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
ARAYAccuray IncGMEDGlobus Medical IncIARTIntegra Lifesciences Holdings CorpICUIIcu Medical IncIRTCIrhythm Technologies IncMDXGMimedx Group IncMMSIMerit Medical Systems IncNVRONevro CorpPODDInsulet CorpTNDMTandem Diabetes Care Inc